Cargando…
Novel case of androgen receptor‐positive cancer of unknown primary without serum prostate‐specific antigen elevation that became progression free in the long term after primary combined androgen blockade
INTRODUCTION: The prognosis of cancer of unknown primary is very poor. Such a prognosis can be improved by characterizing primary characteristics and developing tailored site‐specific therapy, especially for androgen receptor‐positive adenocarcinoma. However, in such cases without elevated prostate‐...
Autores principales: | Matsuyama, Nayuka, Naiki, Taku, Naiki‐Ito, Aya, Chaya, Ryosuke, Kawai, Tatsuya, Etani, Toshiki, Nagai, Takashi, Kato, Hiroyuki, Kubota, Yasue, Yasui, Takahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784734/ https://www.ncbi.nlm.nih.gov/pubmed/33426501 http://dx.doi.org/10.1002/iju5.12241 |
Ejemplares similares
-
Early abiraterone acetate treatment is beneficial in Japanese castration-resistant prostate cancer after failure of primary combined androgen blockade
por: Nagai, Takashi, et al.
Publicado: (2018) -
Rare case of immunoglobulin G4‐related disease arising in gonadal glands with long‐term remission without steroid treatment: Discussion and literature review
por: Isobe, Teruki, et al.
Publicado: (2021) -
Testicular seminoma arising from infertile testes 6 years after microdissection testicular sperm extraction
por: Shimizu, Nobuhiko, et al.
Publicado: (2021) -
Recruitment of miR-8080 by luteolin inhibits androgen receptor splice variant 7 expression in castration-resistant prostate cancer
por: Naiki-Ito, Aya, et al.
Publicado: (2020) -
Metastatic Urothelial Carcinoma with Glandular Differentiation That Confirmed the Response by Autopsy Specimen to Second-Line mFOLFOX6 (Fluorouracil, Oxaliplatin, and Leucovorin) plus Bevacizumab Chemotherapy
por: Naiki, Taku, et al.
Publicado: (2017)